SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $86,441,000 | -26.0% | 1,521,580 | -2.6% | 0.10% | -30.4% |
| Q1 2021 | $116,884,000 | -15.2% | 1,561,573 | -2.0% | 0.15% | -11.9% |
| Q4 2020 | $137,805,000 | +57.3% | 1,592,933 | +11.1% | 0.17% | +35.5% |
| Q3 2020 | $87,612,000 | +73.4% | 1,433,449 | +17.9% | 0.12% | +53.1% |
| Q2 2020 | $50,538,000 | +101.3% | 1,215,429 | +39.1% | 0.08% | +50.0% |
| Q1 2020 | $25,102,000 | -40.6% | 874,039 | +49.3% | 0.05% | -27.0% |
| Q4 2019 | $42,263,000 | -48.1% | 585,439 | +0.9% | 0.07% | -51.9% |
| Q3 2019 | $81,376,000 | -24.2% | 580,057 | -1.1% | 0.15% | -22.2% |
| Q2 2019 | $107,418,000 | +20.1% | 586,696 | +4.3% | 0.20% | +12.5% |
| Q1 2019 | $89,430,000 | +272.8% | 562,278 | +124.5% | 0.18% | +225.9% |
| Q4 2018 | $23,989,000 | – | 250,431 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |